Antireumatski lek (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Antireumatski lek" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

2mercksource.com

8,363^rd place

508^th place

2^nd place

2^nd place

4^th place

3^rd place

1web.archive.org

1^st place

1^st place

3,771^st place

2,312^th place

low place

2,251^st place

1,226^th place

501^st place

bmj.com

ard.bmj.com

Capell HA, Madhok R, Porter DR, et al. (February 2007). „Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double‐blind placebo‐controlled MASCOT study”. Annals of the rheumatic diseases 66 (2): 235–41. DOI:10.1136/ard.2006.057133. PMC 1798490. PMID 16926184.

doi.org

dx.doi.org

Nandi P, Kingsley GH, Scott DL (May 2008). „Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis”. Current opinion in rheumatology 20 (3): 251–6. DOI:10.1097/BOR.0b013e3282fb7caa. PMID 18388514.
Capell HA, Madhok R, Porter DR, et al. (February 2007). „Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double‐blind placebo‐controlled MASCOT study”. Annals of the rheumatic diseases 66 (2): 235–41. DOI:10.1136/ard.2006.057133. PMC 1798490. PMID 16926184.

mercksource.com

nih.gov

ncbi.nlm.nih.gov

Nandi P, Kingsley GH, Scott DL (May 2008). „Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis”. Current opinion in rheumatology 20 (3): 251–6. DOI:10.1097/BOR.0b013e3282fb7caa. PMID 18388514.
Capell HA, Madhok R, Porter DR, et al. (February 2007). „Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double‐blind placebo‐controlled MASCOT study”. Annals of the rheumatic diseases 66 (2): 235–41. DOI:10.1136/ard.2006.057133. PMC 1798490. PMID 16926184.

uptodate.com

„Disease modifying antirheumatic drugs (DMARDs)”. Arhivirano iz originala na datum 2009-04-26.

web.archive.org

„Disease modifying antirheumatic drugs (DMARDs)”. Arhivirano iz originala na datum 2009-04-26.

wkhealth.com

meta.wkhealth.com

Nandi P, Kingsley GH, Scott DL (May 2008). „Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis”. Current opinion in rheumatology 20 (3): 251–6. DOI:10.1097/BOR.0b013e3282fb7caa. PMID 18388514.